GENOMMA LAB INTERNAC regular Real Value cannot be determined due to lack of data. The prevalent price of GENOMMA LAB INTERNAC is 0.0. Based on Macroaxis valuation methodology, the corporation cannot be evaluated at this time. This module calculates value of GENOMMA LAB INTERNAC from examining the corporation fundamentals such as Return On Equity of
11.86%, Operating Margin of 19.80% and Return On Asset of 8.40% as well as analyzing its technical indicators and Probability Of Bankruptcy. In general, we encourage to acquire undervalued assets and to sell overvalued assets since in the future stocks prices and their ongoing real values will come together.
|Horizon||30 Days Login to change|
GENOMMA LAB INTERNACIONAL SAB is currently regarded as number one stock in price to earning category among related companies. It is currently regarded as number one stock in beta category among related companies totaling about 0.03 of Beta per Price to Earning. The ratio of Price to Earning to Beta for GENOMMA LAB INTERNACIONAL SAB is roughly 38.17
|Price to Earning ( times )|